Neurodevelopmental and psychiatric comorbidities in children with epilepsy
Developmental Medicine & Child Neurology · 15.05.2026
DOI: 10.1111/dmcn.70302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 15.05.2026. Verfasst von Maria Hafström und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Institute of Clinical Science, University of Gothenburg, Gothenburg, Sweden. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Margaretahemmet research fund 2021-008, Region Halland grants - Vetenskapliga rådet, Region Halland grants - Sparbanksstiftelsen.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aim
To determine the prevalence of neurodevelopmental, psychiatric, and sleep comorbidities, and combined comorbidities among children with ‘active’ epilepsy.
Method
All children (born 2003–2021) in the Region Västra Götaland, Sweden with active epilepsy in 2020 and 2021 were included in this population‐based cross‐sectional study. Diagnoses according to the International Classification of Diseases between 2003 and 2021 for autism spectrum disorder, intellectual disability, attention‐deficit/hyperactivity disorder, cerebral palsy, psychological developmental disorders, psychiatric disorders, and sleep disorders and information on associated dispensed drugs, from 31st August 2010, were extracted from all healthcare use from hospitals, outpatient specialist care, habilitation centres, and primary care in the region.
Results
Active epilepsy was diagnosed in 0.56% (2146 out of 383 870) of children, 70% had at least one comorbidity, and 40% had diagnoses in three or more of the seven included comorbidity domains. The most frequent comorbidities were in the psychiatric, psychological developmental, sleep, and intellectual disability domains. Associations between comorbidities varied, some being greater in female children than in males.
Interpretation
Children with active epilepsy have a high risk of having multiple neurodevelopmental and psychiatric comorbidities. Individualized, comprehensive, and long‐term follow‐up for possible comorbidities is necessary.
Autor:innen und Institutionen
- Department of Pediatrics, Institute of Clinical Science, University of Gothenburg, Gothenburg, Sweden.
- Angered Hospital, SV Hospital Group, Gothenburg, Sweden.
- Department of Pediatrics, Kungsbacka Hospital, Kungsbacka, Sweden.
- School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Sweden, Sweden.
- Department of Child Neurology, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Institute of Neuroscience and Physiology, Sahlgrenska Academy University of Gothenburg, Sweden.
ORCID-Profile: Maria Hafström, Johan Zelano, Jonas Hermansson
Förderung
- Margaretahemmet research fund 2021-008
- Region Halland grants - Vetenskapliga rådet
- Region Halland grants - Sparbanksstiftelsen
- Regional Research grants, Angereds Närsjukhus, Region Västra Götaland grants
- Swedish Research Council
- Knut och Ragnvi Jacobsson foundation
- Swedish state through the ALF-agreement
- Vetenskapsrådet
Zitieren
APA
Hafström, M., Mehlig, K., Olsson, I., Reilly, C., Zelano, J., & Hermansson, J. (2026). Neurodevelopmental and psychiatric comorbidities in children with epilepsy. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.70302
Vancouver
Hafström M, Mehlig K, Olsson I, Reilly C, Zelano J, Hermansson J. Neurodevelopmental and psychiatric comorbidities in children with epilepsy. Developmental Medicine & Child Neurology. 2026. doi:10.1111/dmcn.70302
BibTeX
@article{Hafstrm2026,
author = {Hafström, Maria and Mehlig, Kirsten and Olsson, Ingrid and Reilly, Colin and Zelano, Johan and Hermansson, Jonas},
title = {Neurodevelopmental and psychiatric comorbidities in children with epilepsy},
journal = {Developmental Medicine & Child Neurology},
year = {2026},
doi = {10.1111/dmcn.70302}
}
EUVIMED